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Abstract 
The current study deals with the development of a low-cost iontophoretic delivery system. 
Iontophoresis deals with the administration of the drug under the influence of electrical potential. 
A low-cost portable and user friendly pulsed iontophoretic system was developed. The efficiency 
of the system, at various duty cycles, was analysed against the salicylic acid (SA)-loaded gelatin 
gels. The current density for the studies was maintained at 0.5 mA/cm
2
. The results indicated that 
as the duty cycle was increased there was a subsequent increase in the drug release from the 
gelatin gels. 100 % duty cycle provided the best release behaviour in terms of % SA release. 
Taking this as the reference duty cycle, the SA release from the alginate-gelatin and chitosan-
gelatin gels were also studied. The results indicated that as the proportion of alginate was 
increased in the alginate-gelatin gels, there was an increase in the % release whereas there was a 
decrease in the SA release as the chitosan proportion was increased in the chitosan-gelatin gels. 
The release patterns indicated that the release from the gels followed Higuchian kinetics. 
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1.1. Background 
Iontophoresis may be defined as a phenomenon, which involves the use of electric potential 
to drive an ionic solute into the systemic circulation without any invasive procedures [1]. 
This technique has been classified as transdermal delivery system [2]. The non-invasive 
nature of the method has led to the increase in the patient compliance [3]. This has been 
attributed to the various disadvantages of the conventional delivery systems, viz. oral and 
parenteral delivery systems. Since the procedure allows the administration of the drug 
directly into the systemic circulation, various drugs with short shelf-life may also be tried as a 
formulation [4]. The potential of this technique has been exploited by various researches for 
the transdermal delivery of many drugs with poor penetration properties (e.g. high molecular 
weight electrolytes such as proteins, peptides and oligonucleotides) which are normally 
difficult to administer except through parenteral route [5]. Most of the drug molecules are 
ionic species which allows the administration of the drug using electric potential by 
facilitating its easy penetration through the skin into the systemic circulation [6].   
 
Figure1. Schematic diagram of an iontophoretic system 
 
The schematic diagram of an iontophoretic system has been shown in figure 1. It is clear 
from the diagram that an electric current has to pass through the patient’s body for delivering 
the drugs. This is because a stringent electrical safety protocol has to be followed. As a matter 
of fact, various approaches have been used for ensuring patient safety. The methods which 
have gained much importance include the use of a battery powered system and the use of dc-
dc converters (figure 2). Apart from the above, US FDA has set the maximum limit for the 
current density through the electrodes as 0.5mA/cm
2
 for a typical iontophoretic system to 
avoid any discomfort to the patients [7].  
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Figure2. Schematic diagram of a power isolation circuit employing dc-dc converter for 
patient isolation 
 
1.2. Project Outline 
The current study deals with the development of a low-cost portable iontophoretic system. 
The efficiency of the system was determined against SA-loaded gelatin gels. Attempts were 
also made to study the effect of polyelectrolytes (e.g. sodium alginate and chitosan) on the 
release pattern of the SA. 
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2.1. Materials used  
Atmega-32 MCU was procured from Atmel, CA, USA while JHD 162A LCD module was 
procured from Hitachi India, New Delhi, India. A 4x4 matrix keypad was obtained from 
Robokits, Ahmedabad, India. All other electronic components (e.g. D880 power transistor, 
470Ω preset, transistor BC 548, LM 317) were procured from the local market. 
Tween 80 (polyxyethylene sorbitan monooleate) and gelatin (commercial grade) were 
procured from Himedia, Mumbai, India. Ethanol was obtained from Honyon International 
Inc., Hong Yang Chemical Corpn., China. Glutaraldehyde (25%, for synthesis; GA) and 
hydrocholric acid (35%pure) was obtained from Merck Specialities Private Limited Mumbai, 
India. Salicylic acid (SA) were procured from Loba Chemie, Mumbai, India   
 
2.2. Circuit designing 
The iontophoretic driver circuit should be able to deliver constant current for a particular 
experimental condition. LM 317 (variable voltage regulator, to be in making a constant 
current source) was used for maintaining constant current during an experiment. It is 
desirable to include suitable LED indicators which may give indications about the running 
modes. The circuit was developed as per the figure 3 and was regarded as driver circuit. 
Atmega-32 (8-bit) microcontroller unit (MCU) was used to drive the driver circuit at various 
duty cycles (e.g. 0 %, 20 %, 40 %, 50 %, 60 %, 80 % and 100 %). The microcontroller 
module was then augmented with a LCD module and a matrix keypad, so as to bring-in easier 
user interface. The schematic diagram of the whole system has been given in figure 4 (real 
picture can be found in Appendix 1 and MCU code can be found in Appendix 2). 
Patient isolation modules can also be augmented with the power source so as to ensure 
patient’s safety when the device is ready to be used on humans. 
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2.3. Circuit diagram  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.Circuit diagram sowing all the essential components
 
Figure 4.Schematic diagram of the entire iontophoresis assembly 
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2.4. In vitro drug release 
In vitro drug release was conducted in a specially designed diffusion cell (figure 6). The 
diffusion cell consists of two donor compartments. The receptor compartment consisted of 
two ports, which allowed the attachment of the donor compartments through semi-permeable 
membranes. Apart from this, receptor compartment also contained a sampling port for 
sampling of the receptor fluid. A schematic diagram of the diffusion cell has been shown in 
figure 5.    
The matrix for the donor compartment with active electrode (cathode) contained SA-loaded 
gelatin gels. The SA-loaded gelatin gels were prepared by mixing 4 ml of 10 % (w/v) SA 
solution with 16 ml of 10 % (w/v) warm gelatin solution [8]. This was followed by the 
addition of the glutaraldehyde reagent (0.5 ml GA + 0.5 ml ethanol + 0.1 ml of HCl). The 
solutions were mixed thoroughly for 30 sec and immediately poured into the donor 
compartment for inducing gel formation. The remaining space, if any, was filled with blank 
gelatin solution. In the similar manner the passive electrode (anode) was also filled with 
gelatin-only gels (16 ml gelatin sol) containing 4ml of normal saline. Thereafter, the donor 
compartments were brought in contact with the receptor compartments, filled with distilled 
water and having cellulose acetate membrane as the semipermeable membranes and pulsed 
potential of various duty cycles were applied. Care was taken so that the current density did 
not increase 0.5mA/cm
2
. At regular intervals of time, 10 min for first 1 h and 20 min interval 
for the next 2 h, samples of 3 ml was drawn from the receptor and was replenished with fresh 
3 ml water. The sampled solutions were analysed using UV-vis. spectrophotometer 
(Sistronics Double Beam Spectrophotometer model number 2303) at 294 nm. 
In similar experiments, various proportions of chitosan-gelatin and alginate-gelatin blends 
were used to make the donor matrices (table 1a & 1b). 2.5% of chitosan solution was 
prepared by dissolving 0.5 g of chitosan in 8 ml of 99.5% glacial acetic acetic acid and then 
taking finally diluting with 12 ml of water. 10% of alginate solution was prepared by 
dissolving 2 g of alginate in 20 ml of water. The polyelectrolyte and gelatin solutions were 
mixed in various proportions and treated with GA reagent to develop matrices as describe in 
the previous paragraph. The duty cycle, which provided best result with the gelatin gels, was 
used in the study to compare the effects of the polyelectrolytes on the drug release properties.   
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Table 1a: Table of Compositions for Gelatin-Chitosan gels 
Sample Vol. of  Gelatin sol (ml) Vol. of  Chitosan sol (ml) 
GC0 20 0 
GC1 12 8 
GC2 8 12 
GC3 0 20 
 
Table 1b: Table of Compositions for Gelatin-Alginate gels 
Sample Vol. of  Gelatin sol (ml) Vol. of  Alginate sol (ml) 
GA0 20 0 
GA1 12 8 
GA2 8 12 
GA3 0 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.CAD model of the diffusion apparatus (all 
dimensions in cm) 
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3. Drug release study of Gelatin gels 
The preliminary experimentations were carried out using SA-loaded gelatin gels as the 
conducting matrices. They were subjected to different duty cycles of pulsed dc (Vp= 10.5) 
voltages. The release profile of SA through the gelatine gels have been shown in figure 6. 
The results indicated that as the duty cycle was increased from 0% to 100 %, there was an 
increase in the rate of release of the drug. The % release of the drug varied from 67.1 % 
during passive diffusion and 72.22 % when 100 % duty cycle of the dc voltage was applied. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.Graphical plot of percentage drug released vs. time, Gelatin gels  
The release kinetics of SA from the gelatin gels were studied by analyzing for zero order, 
first order and Higuchian models. The results of the kinetics studies have been tabulated in 
table 2. The results indicated that the release of SA from the gels followed Higuchian kinetics 
[9], (table 2 and figure 7). Since the SA-loaded gelatin gels contained SA molecules 
uniformly distributed throughout the gelatin matrices, this can explain the Higuchian release 
kinetics for SA from the geltain gels. 
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Table 2: R2values for Gelatin gels 
Duty cycle 
(%) 
r
2
 for model fitting Best fit 
Zero order 
model 
First order 
model 
Higuchi model 
0 0.88102 0.92398 0.96899 Higuchi 
20 0.9066 0.94532 0.97967 Higuchi 
40 0.9285 0.96494 0.99153 Higuchi 
50 0.93258 0.9685 0.98513 Higuchi 
60 0.90575 0.95065 0.98396 Higuchi 
80 0.94534 0.98172 0.98614 Higuchi 
100 0.9324 0.97955 0.98704 Higuchi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.Graphical plot of percentage drug released vs. sqrt. time (Higuchi model), Gelatin gels 
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Gelatin is a neutral polymer. To determine the effect of the polyeletrolytes (e.g. chitosan and 
alginate), another set of experiment was carried out by preparing matrices by blending 
chitosan & gelatin and alginate & gelatin polymers. Since 100 % duty cycle gave us the best 
release profile from the SA loaded gelatin gels, it was selected for the further studies with the 
polyelectrolyte matrices. When chitosan and alginate was used as polyelectrolytes, the pulsed 
dc with Vp of 8.2 was used. This was done to ensure that the current density did not increase 
beyond 0.5 mA/ cm
2
. When chitosan was used as polyelectrolyte, the release results indicated 
that with the increased proportion of chitosan in the matrix, there was a marked decrease of 
the SA release (figure 8). For GC3, the release was found to be 34.66 % whereas when GC0 
was used, the release was found to be 63.00 %. When alginate was used as polyelectrolyte, 
the release results indicated that with the increased proportion of alginate in the matrix, there 
was a marked increase of the SA release (figure 9). For GA3, the release was found to be 
71.59 % whereas when GA0 was used, the release was found to be 63 %.  
The observed release results may be explained by the fact that the SA, being an anion, 
interacts ionically with the cationic amino groups of the chitosan polymer. This plays an 
important role in hindering the release of SA from matrices. With the increased amount of 
chitosan, the interaction amongst the SA and the chitosan becomes stronger and hence the 
lower % release of SA (figure 8). On the other hand, SA and alginate, both being anions, 
repel each other with minimal associative interactions amongst them. Hence, as the potential 
is applied, it provides an additional outward thrust on the SA molecules thereby resulting in 
the quick release of the SA molecules from the matrices.  With the increased amount of 
alginate, the interaction amongst the SA and the matrices becomes weaker and hence the 
higher % release of SA (figure 9). Gelatin being a neutral polymer, showed release profile in 
between the chitosan and alninate matrices (figure 8 and 9). 
The release kinetics of SA from the gels was studied by analyzing for zero order, first order 
and Higuchian models. The results of the kinetics studies have been tabulated in table 3a and 
3b. The results indicated that the release of SA from the gels followed Higuchian kinetics 
(table 3a, 3b and figure 10, 11). 
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Figure 8.Graphical plot of percentage drug released vs. time, Gelatin-Chitosan gels 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.Graphical plot of percentage drug released vs. time, Gelatin-Alginate gels 
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Table 3a: R2values for Gelatin-Chitosan gels 
Sample r
2
 for model fitting Best fit 
Zero order First order Higuchi model 
GC3 0.96591 0.97949 0.98339 Higuchi 
GC2 0.97358 0.99335 0.9943 Higuchi 
GC1 0.91704 0.96272 0.98174 Higuchi 
GC0 0.85559 0.93902 0.97609 Higuchi 
 
Table 3b: R2values for Gelatin-Alginate gels 
Sample r
2
 for model fitting Best fit 
Zero order First order Higuchi model 
GA3 0.78491 0.8826 0.91781 Higuchi 
GA2 0.80404 0.9016 0.93069 Higuchi 
GA1 0.82473 0.9118 0.94564 Higuchi 
GA0 0.85559 0.93902 0.97609 Higuchi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.Graphical plot of percentage drug released vs. sqrt. time (Higuchi model), Gelatin-
Chitosan gels 
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Figure 11.Graphical plot of percentage drug released vs. sqrt. time (Higuchi model), Gelatin-
Alginate gels 
 
 
 
 
 
3 6 9
20
40
60
20
40
60
20
40
60
802
40
60
80
 
Sqrt Time
 GA0
Rsq. =0.97609
 
 GA1
Rsq. =0.94564
 
c
p
r 
v
a
lu
e
s
 GA2
Rsq. =0.93069
 
 GA3
Rsq. =0.91781
16 
 
Chapter 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Conclusion 
 
 
 
17 
 
In the current study, successful attempts were made to develop low-cost, portable and user-
friendly iontophoretic delivery system. The system was tested by using polymers, either alone 
or in combination with each other, as a matrix for Salicylic acid (model drug). The release 
study indicated that with increase in the duty cycle of the pulsed DC voltage there was a 
subsequent increase in the release rate. Salicylic acid (anionic) was hindered when Chitosan 
based gels were used; whereas when Alginate based gels were used there was an increase in 
release rate. Gelatin, being neutral in nature, showed release rate which were in between 
release rates of chitosan and Alginate based gels. All the matrix system showed Higuchian 
kinetics of release.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
References 
1. Kalia, Y.N., et al., Iontophoretic drug delivery. Advanced drug delivery reviews, 
2004. 56(5): p. 619-658. 
2. Chien, Y.W., et al., Direct current iontophoretic transdermal delivery of peptide and 
protein drugs. Journal of pharmaceutical sciences, 1989. 78(5): p. 376-383. 
3. Pauwels, R., et al., COPD exacerbations: the importance of a standard definition. 
Respiratory medicine, 2004. 98(2): p. 99-107. 
4. Balant, L., E. Doelker, and P. Buri, Prodrugs for the improvement of drug absorption 
via different routes of administration. European journal of drug metabolism and 
pharmacokinetics, 1990. 15(2): p. 143-153. 
5. Dixit, N., et al., Iontophoresis-an approach for controlled drug delivery: a review. 
Current drug delivery, 2007. 4(1): p. 1-10. 
6. Nair, V., et al., Transdermal iontophoresis. Part I: Basic principles and 
considerations. Methods Find. Exp. Clin. Pharmacol, 1999. 21(2). 
7. Hirvonen, J., Topical Iontophoretic Delivery: Progress to Date and Therapeutic 
Potential. American Journal of Drug Delivery, 2005. 3(2): p. 67-81. 
8. Niamlang, S. and A. Sirivat, Electric field assisted transdermal drug delivery from 
salicylic acid-loaded polyacrylamide hydrogels. Drug Delivery, 2009. 16(7): p. 378-
388. 
9. Schwartz, J.B., A.P. Simonelli, and W.I. Higuchi, Drug release from wax matrices I. 
Analysis of data with first order kinetics and with the diffusion controlled model. 
Journal of pharmaceutical sciences, 1968. 57(2): p. 274-277. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
Appendix 
1. The following figure is the colour snap of the iontophoretic device 
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2. Driver program with LCD display, C-code 
#include<avr/io.h> 
#include"timer1.h" 
#include"lcd.h" 
#define hundred 15624 
#define eighty 12500 
#define sixty 9375 
#define fifty 7812 
#define fourty 6250 
#define twenty 3125 
void screen1(void); 
void screen2(void); 
void screen3(void); 
void screen4(void); 
void select(unsigned int duty); 
void driver(char onoff); 
unsigned int i=0; 
int main() 
{ 
 DDRB=0xff; 
 timer_set_top(15624); 
 timer_init(clk_64,Fast_pwm_top_ICR1,clear_on_cmp,'B'); 
 lcd_init(); 
 DDRD=0xFF; 
 lcd_invisible_cursor(); 
 screen1(); 
 return 0; 
} 
void screen1() 
{ 
 lcd_clear(); 
 lcd_position(0,0); 
 lcd_print("IONTOPHORETIC DRUG DELIVERY"); 
 lcd_position(1,0); 
 lcd_print("PRESS:1 TO CONTINUE"); 
 while(1) 
 { 
  lcd_scroll_left(); 
  if((PINB & 0xFF)== 0x01) 
   break; 
 } 
 screen2(); 
 _delay_ms(30); 
} 
void screen2() 
{ 
 lcd_clear(); 
 set_compare_register(0,'B'); 
 driver(0); 
 lcd_position(0,0); 
 lcd_print("Select Duty Cycle. 100%=1,80%=2"); 
 lcd_position(1,0); 
 lcd_print("60%=3,50%=4,40%=5,20%=6,0%=7"); 
 while(1) 
 { 
  lcd_scroll_left(); 
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  if((PINB & 0x0F)==1) 
  { 
   i=hundred; 
   break; 
  } 
  if((PINB & 0x0F)==2) 
  { 
   i=eighty; 
   break; 
  } 
  if((PINB & 0x0F)==4) 
  { 
   i=sixty; 
   break; 
  } 
  if((PINB & 0x0F)==8) 
  { 
   i=fifty; 
   break; 
  } 
  if((PINB & 0xFF)==0x10) 
  { 
   i=fourty; 
   break; 
  } 
  if((PINB & 0xFF)==0x20) 
  { 
   i=twenty; 
   break; 
  } 
  if((PINB & 0xFF)==0x40) 
  { 
   i=0; 
   break; 
  }   
 } 
 _delay_ms(30); 
 screen3(); 
} 
 
void screen3() 
{ 
 lcd_clear(); 
 lcd_position(0,0); 
 lcd_print("DUTY CYCLE SELECTED="); 
 if(i==hundred) 
  lcd_print(" 100%"); 
 if(i==eighty) 
  lcd_print(" 80%"); 
 if(i==sixty) 
  lcd_print(" 60%");    
 if(i==fifty) 
  lcd_print(" 50%"); 
 if(i==fourty) 
  lcd_print(" 40%");     
 if(i==twenty) 
  lcd_print(" 20%");  
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 if(i==0) 
  lcd_print(" 0%"); 
 lcd_position(1,0); 
 lcd_print("PRESS:1 TO RUN, 2 TO RESELECT"); 
 while(1) 
 { 
  lcd_scroll_left(); 
  if((PINB & 0x0F)==1) 
   screen4(); 
  if((PINB & 0x0F)==2) 
   screen2(); 
 } 
} 
void select(unsigned int duty) 
{ 
 set_compare_register(duty,'B'); 
 if(duty) 
  driver(1); 
 else 
  driver(0); 
} 
void screen4() 
{ 
 lcd_clear(); 
 if(i==hundred) 
  lcd_print("Duty Cycle= 100%"); 
 if(i==eighty) 
  lcd_print("Duty Cycle= 80%"); 
 if(i==sixty) 
  lcd_print("Duty Cycle= 60%");    
 if(i==fifty) 
  lcd_print("Duty Cycle= 50%"); 
 if(i==fourty) 
  lcd_print("Duty Cycle= 40%");     
 if(i==twenty) 
  lcd_print("Duty Cycle= 20%"); 
 if(i==0) 
  lcd_print("Duty Cycle= 0%"); 
 select(i); 
 lcd_position(1,0); 
 lcd_print("RESELCT=1,PAUSE=2,RESUME=3"); 
 while(1) 
 { 
  lcd_scroll_left(); 
  if((PINB & 0xFF)== 0x01) 
  { 
   screen1(); 
   break; 
  } 
  if((PINB & 0xFF)== 0x02) 
  { 
   lcd_position(0,0); 
   lcd_clear(); 
   lcd_print("PAUSED"); 
   lcd_position(1,0); 
   lcd_print("RESELCT=1,PAUSE=2,RESUME=3"); 
   select(0); 
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  } 
  if((PINB & 0xFF)== 0x04) 
  { 
   lcd_clear(); 
   if(i==hundred) 
    lcd_print("Duty Cycle= 100%"); 
   if(i==eighty) 
    lcd_print("Duty Cycle= 80%"); 
   if(i==sixty) 
    lcd_print("Duty Cycle= 60%");    
   if(i==fifty) 
    lcd_print("Duty Cycle= 50%"); 
   if(i==fourty) 
    lcd_print("Duty Cycle= 40%");     
   if(i==twenty) 
    lcd_print("Duty Cycle= 20%");  
   if(i==0) 
    lcd_print("Duty Cycle= 0%");  
   select(i); 
   lcd_position(1,0); 
   lcd_print("RESELCT=1,PAUSE=2,RESUME=3"); 
  } 
 } 
} 
void driver(char onoff) 
{ 
 if(onoff==1) 
  PORTD|=0x01; 
 if(onoff==0) 
  PORTD&=~(0x01); 
} 
